Insider · CIK 0001236447
Paul Schimmel
Files at ATYR (aTYR PHARMA INC). First filing Oct 9, 2025, latest May 28, 2026.
In brief
Paul Schimmel files SEC Form 4 as director at ATYR (aTYR PHARMA INC). Since Oct 9, 2025, Paul Schimmel has reported 2 open-market buys worth $961k and 0 open-market sells worth $0, the latest filed on May 28, 2026.
A track record needs three past buys with six months of prices behind them; Paul Schimmel has 1, so none is measured yet.
The newest scored trade: bought $50k of ATYR on May 27, 2026, filed May 28, 2026, scored 33 (weak). In the last 12 months: 1 buy worth $50k and 0 sells worth $0.
Where the trades landed
Last year at the company this insider has traded most, with each buy and sell on the bar it happened.
ATYR: aTYR PHARMA INC
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 33Weak | ATYRbuy aTYR PHARMA INC | $50k 100,000 shares | +15% | +21% from low-93% from high | |
| 57Moderate | ATYRbuy aTYR PHARMA INC | $912k 1,000,000 shares | +242% | +45% from low-85% from high |
Transactions
Every row this insider has filed, 5 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| May 27, 2026 | ATYR aTYR PHARMA INC | POpen-market purchase Common Stockindirect: See Footnote | +100,000 | $0.50 | $50k | 779,143 | May 28, 2026 |
| May 11, 2026 | ATYR aTYR PHARMA INC | AGrant or award Stock Option (right to buy)derivative | +50,000 | $0.00 | $0 | 50,000 | May 13, 2026 |
| Oct 8, 2025 | ATYR aTYR PHARMA INC | POpen-market purchase Common Stockindirect: See Footnote | +682,001 | $0.90 | $612k | 1,095,024 | Oct 9, 2025 |
| Oct 9, 2025 | ATYR aTYR PHARMA INC | POpen-market purchase Common Stockindirect: See Footnote | +317,999 | $0.94 | $299k | 1,413,023 | Oct 9, 2025 |
| May 1, 2025 | ATYR aTYR PHARMA INC | AGrant or award Stock Option (right to buy)derivative | +50,000 | $0.00 | $0 | 50,000 | May 2, 2025 |
Questions about Paul Schimmel
Answered from the filings on this page, as of the latest one.
Is Paul Schimmel buying or selling?
In the last 12 months Paul Schimmel reported 1 open-market buy worth $50k and 0 open-market sells worth $0 on SEC Form 4; the latest was bought $50k of ATYR on May 27, 2026. Grants, option exercises and tax withholding are not counted.
How did Paul Schimmel's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Paul Schimmel has 1.
Where does Paul Schimmel file Form 4?
Paul Schimmel has filed Form 4 at ATYR (aTYR PHARMA INC). A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.